EP3003348 - CHIMERAS OF BRUCELLA LUMAZINE SYNTHASE AND BETA SUBUNIT OF AB5 TOXINS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 03.07.2020 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 07.06.2019 | ||
Former | Grant of patent is intended Status updated on 03.12.2018 | ||
Former | Examination is in progress Status updated on 06.01.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Inmunova S.A. 25 de mayo 574 Piso 2 Of. 12 1642 San Isidro - Pcia. de Buenos Aires / AR | For all designated states Consejo Nacional De Investigaciones Cientificas Y Tecnicas Avda. Rivadavia 1917 C1033AAJ Buenos Aires / AR | [2019/22] |
Former [2019/21] | For all designated states Inmunova S.A. 25 de mayo 574 Piso 2 Of. 12 1642 San Isidro - Pcia. de Buenos Aires / AR | ||
Former [2016/15] | For all designated states Inmunova S.A. 25 de mayo 574 Piso 2 Of. 12 1642 San Isidro - Pcia. de Buenos Aires / AR | ||
For all designated states Spatz, Martín, Diego, Linus Dorrego 1441 B1644BSC Victoria - Pcia. de Buenos Aires / AR | Inventor(s) | 01 /
SPATZ, Martín, Diego, Linus Dorrego 1441 B1644BSC Victoria - Pcia. de Buenos Aires / AR | 02 /
GOLDBAUM, Fernando, Alberto Araoz 2719 piso 8 1425 Ciudad Autónoma de Buenos Aires / AR | 03 /
ZYLBERMAN, Vanesa Zarraga 3779 piso 1 1427 Ciudad Autónoma de Buenos Aires / AR | 04 /
CRAIG, Patricio, Oliver Olazabal 1447 - 6A 1428 Ciudad Autónoma de Buenos Aires / AR | 05 /
GHERSI, Giselle Quintino Bocayuva 1171 1257 Ciudad Autónoma de Buenos Aires / AR | 06 /
PALERMO, Marina, Sandra Udet 435 - Ciudad Jardin 1684 Palomar - Pcia. de Buenos Aires / AR | 07 /
MEJIAS, Maria, Pilar Mitre 667 Dto. 16A 1878 Quilmes - Pcia. de Buenos Aires / AR | 08 /
BENTANCOR, Leticia, Veronica Necochea 1307 1888 Florencio Varela - Pcia. de Buenos Aires / AR | [2016/15] | Representative(s) | Hoffmann Eitle Hoffmann Eitle S.L.U. Paseo de la Castellana 140, 3a planta Edificio LIMA 28046 Madrid / ES | [2019/28] |
Former [2016/15] | Høiberg A/S St. Kongensgade 59 A 1264 Copenhagen K / DK | Application number, filing date | 14736442.6 | 26.05.2014 | [2016/15] | WO2014IB61731 | Priority number, date | US201361827713P | 27.05.2013 Original published format: US 201361827713 P | [2016/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014191903 | Date: | 04.12.2014 | Language: | EN | [2014/49] | Type: | A1 Application with search report | No.: | EP3003348 | Date: | 13.04.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 04.12.2014 takes the place of the publication of the European patent application. | [2016/15] | Type: | B1 Patent specification | No.: | EP3003348 | Date: | 10.07.2019 | Language: | EN | [2019/28] | Search report(s) | International search report - published on: | EP | 04.12.2014 | Classification | IPC: | A61K38/16, A61K39/02, A61K39/108 | [2016/15] | CPC: |
C12N9/1085 (EP,US);
A61K38/45 (EP,MX,US);
A61K39/0258 (EP,MX,US);
A61K39/098 (EP,MX,US);
A61P13/12 (EP);
A61P31/04 (EP);
A61P37/04 (EP);
A61P7/00 (EP);
C07K14/245 (US);
C07K16/1232 (EP,US);
C07K16/18 (EP,US);
C07K16/40 (US);
A61K2039/505 (EP,US);
A61K2039/523 (EP,US);
A61K2039/545 (EP,US);
A61K2039/55505 (EP,US);
A61K2039/55566 (EP,US);
A61K2039/575 (US);
A61K2039/6037 (US);
A61K2039/6068 (EP,US);
A61K38/00 (EP,US);
C07K2317/20 (US);
C07K2317/22 (EP,US);
C07K2317/31 (EP,US);
C07K2317/565 (EP,US);
C07K2317/569 (EP,US);
C07K2317/76 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/15] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | CHIMÄREN AUS BRUCELLA-LUMAZIN-SYNTHASE UND BETA-UNTEREINHEIT VON AB5-TOXINEN | [2016/15] | English: | CHIMERAS OF BRUCELLA LUMAZINE SYNTHASE AND BETA SUBUNIT OF AB5 TOXINS | [2016/15] | French: | CHIMÈRES DE LUMAZINE SYNTHASE DE BRUCELLA ET SOUS-UNITÉ BÊTA DES TOXINES AB5 | [2016/15] | Entry into regional phase | 04.01.2016 | National basic fee paid | 04.01.2016 | Designation fee(s) paid | 04.01.2016 | Examination fee paid | Examination procedure | 27.03.2015 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 18.12.2015 | Amendment by applicant (claims and/or description) | 04.01.2016 | Examination requested [2016/15] | 11.01.2017 | Invitation to indicate the basis for amendments (Time limit: M01) | 14.02.2017 | Reply to an invitation to indicate the basis for amendments | 23.02.2017 | Despatch of a communication from the examining division (Time limit: M02) | 28.04.2017 | Reply to a communication from the examining division | 04.09.2017 | Despatch of a communication from the examining division (Time limit: M04) | 05.01.2018 | Reply to a communication from the examining division | 10.09.2018 | Despatch of a communication from the examining division (Time limit: M02) | 29.10.2018 | Reply to a communication from the examining division | 04.12.2018 | Communication of intention to grant the patent | 12.04.2019 | Fee for grant paid | 12.04.2019 | Fee for publishing/printing paid | 12.04.2019 | Receipt of the translation of the claim(s) | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/32] | Fees paid | Renewal fee | 23.05.2016 | Renewal fee patent year 03 | 26.05.2017 | Renewal fee patent year 04 | 23.05.2018 | Renewal fee patent year 05 | 28.05.2019 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 26.05.2014 | AL | 10.07.2019 | AT | 10.07.2019 | CY | 10.07.2019 | CZ | 10.07.2019 | DK | 10.07.2019 | EE | 10.07.2019 | FI | 10.07.2019 | HR | 10.07.2019 | LT | 10.07.2019 | LV | 10.07.2019 | MC | 10.07.2019 | MK | 10.07.2019 | MT | 10.07.2019 | PL | 10.07.2019 | RO | 10.07.2019 | RS | 10.07.2019 | SI | 10.07.2019 | SK | 10.07.2019 | SM | 10.07.2019 | TR | 10.07.2019 | BG | 10.10.2019 | NO | 10.10.2019 | GR | 11.10.2019 | IS | 10.11.2019 | PT | 11.11.2019 | IE | 26.05.2020 | LU | 26.05.2020 | BE | 31.05.2020 | CH | 31.05.2020 | LI | 31.05.2020 | [2022/32] |
Former [2022/27] | HU | 26.05.2014 | |
AL | 10.07.2019 | ||
AT | 10.07.2019 | ||
CY | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
MT | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
IE | 26.05.2020 | ||
LU | 26.05.2020 | ||
BE | 31.05.2020 | ||
CH | 31.05.2020 | ||
LI | 31.05.2020 | ||
Former [2021/24] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
IE | 26.05.2020 | ||
LU | 26.05.2020 | ||
BE | 31.05.2020 | ||
CH | 31.05.2020 | ||
LI | 31.05.2020 | ||
Former [2021/20] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
IE | 26.05.2020 | ||
LU | 26.05.2020 | ||
CH | 31.05.2020 | ||
LI | 31.05.2020 | ||
Former [2021/15] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
LU | 26.05.2020 | ||
CH | 31.05.2020 | ||
LI | 31.05.2020 | ||
Former [2021/12] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
CH | 31.05.2020 | ||
LI | 31.05.2020 | ||
Former [2021/07] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
CH | 31.05.2020 | ||
LI | 31.05.2020 | ||
Former [2020/37] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/36] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/27] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/25] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SK | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/24] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/23] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/22] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
RS | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/17] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
RS | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/15] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
RS | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/12] | AT | 10.07.2019 | |
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
RS | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/11] | AT | 10.07.2019 | |
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
RS | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
Former [2020/10] | AT | 10.07.2019 | |
FI | 10.07.2019 | ||
LT | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
PT | 11.11.2019 | ||
Former [2020/09] | FI | 10.07.2019 | |
LT | 10.07.2019 | ||
NO | 10.10.2019 | ||
Former [2020/08] | LT | 10.07.2019 | |
NO | 10.10.2019 | Cited in | International search | [Y]WO2005121330 (GOLDGENE LLC [AR]) [Y] 1-42 * The whole document, in particular, Example 13, Fig.28 (peptides with >95% identity to SEQ ID NO:3 and 5) *; | [Y]CN102532324 (QINGDAO BAOMAIDE BIOLOG MEDICAL TECHNOLOGY CO LTD) [Y] 1-42 * The whole document, in particular, SEQ ID NO: 2 and 12 (>95% identity to SEQ ID NO:3,5,7,9 of present application) *; | [Y] - PAULA ALVAREZ ET AL, "Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice", VACCINE, (20130101), vol. 31, no. 5, doi:10.1016/j.vaccine.2012.11.072, ISSN 0264-410X, pages 806 - 812, XP055138225 [Y] 1-42 * the whole document * DOI: http://dx.doi.org/10.1016/j.vaccine.2012.11.072 | [Y] - BELLIDO D ET AL, "Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system", VACCINE, ELSEVIER LTD, GB, vol. 27, no. 1, doi:10.1016/J.VACCINE.2008.10.018, ISSN 0264-410X, (20090101), pages 136 - 145, (20081028), XP025714119 [Y] 1-42 * the whole document * DOI: http://dx.doi.org/10.1016/j.vaccine.2008.10.018 | [Y] - PAOLA MARCATO ET AL, "Immunoprophylactic Potential of Cloned Shiga Toxin 2 B Subunit", THE JOURNAL OF INFECTIOUS DISEASES, (20000330), vol. 183, no. 3, doi:10.1086/318080, ISSN 0022-1899, pages 435 - 443, XP055138263 [Y] 1-42 * the whole document * DOI: http://dx.doi.org/10.1086/318080 | [Y] - L. V. BENTANCOR ET AL, "A DNA Vaccine Encoding the Enterohemorragic Escherichia coli Shiga-Like Toxin 2 A2 and B Subunits Confers Protective Immunity to Shiga Toxin Challenge in the Murine Model", CLINICAL AND VACCINE IMMUNOLOGY, (20090501), vol. 16, no. 5, doi:10.1128/CVI.00328-08, ISSN 1556-6811, pages 712 - 718, XP055138258 [Y] 1-42 * the whole document * DOI: http://dx.doi.org/10.1128/CVI.00328-08 | [XP] - L. V. BENTANCOR ET AL, "Promoter Sequence of Shiga Toxin 2 (Stx2) Is Recognized In Vivo, Leading to Production of Biologically Active Stx2", MBIO, (20131001), vol. 4, no. 5, doi:10.1128/mBio.00501-13, ISSN 2150-7511, pages e00501 - 13, XP055138223 [XP] 1-42 * The whole document, in particular, p.5, col.1, §2 * DOI: http://dx.doi.org/10.1128/mBio.00501-13 | [XP] - M. P. MEJIAS ET AL, "Immunization with a Chimera Consisting of the B Subunit of Shiga Toxin Type 2 and Brucella Lumazine Synthase Confers Total Protection against Shiga Toxins in Mice", THE JOURNAL OF IMMUNOLOGY, (20130805), vol. 191, no. 5, doi:10.4049/jimmunol.1300999, ISSN 0022-1767, pages 2403 - 2411, XP055138224 [XP] 1-42 * the whole document * DOI: http://dx.doi.org/10.4049/jimmunol.1300999 | Examination | - PILAR MEJIAS MARIA ET AL, "Protection of Mice against Shiga Toxin 2 (Stx2)-Associated Damage by Maternal Immunization with a Brucella Lumazine Synthase-Stx2 B Subunit Chimera", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20140401), vol. 82, no. 4, doi:10.1128/IAI.00027-14, ISSN 0019-9567, pages 1491 - 1499, XP009179980 DOI: http://dx.doi.org/10.1128/IAI.00027-14 | by applicant | - KAPER ET AL., NAT REV MICROBIOL, (2004), vol. 2, pages 123 - 140 | - KARMALI, CLIN MICROBIOL REV, (1989), vol. 2, pages 15 - 38 | - CAPRIOLI ET AL., VET RES, (2005), vol. 36, pages 289 - 311 | - GRIFFIN; TAUXE, EPIDEMIOLREVL, (1991), vol. 3, pages 60 - 98 | - LOPEZ ET AL., INFECT DIS CLIN NORTH AM, (2000), vol. 14, pages 41 - 65 | - RIVAS ET AL., MEDICINA (B AIRES, (2006), vol. 66, no. 3, pages 27 - 32 | - NOEL; BOEDEKER, DIG DIS, (1997), vol. 15, pages 67 - 91 | - O'BRIEN ET AL., CURR TOP MICROBIOLLMMUNOLL, vol. 80, pages 65 - 94 | - SCHMIDT, RES MICROBIOL, (2001), vol. 152, no. 8, pages 687 - 95 | - STEIN ET AL., NATURE, (1992), vol. 355, no. 6362, pages 748 - 50 | - FRASER ET AL., NAT STRUCT BIOL, (1994), vol. 1, no. 1, pages 59 - 64 | - HIRST ET AL., PROC NATL ACAD SCI U S A, (1984), vol. 81, no. 24, pages 7752 - 6 | - ENDO ET AL., EUR J BIOCHEM, (1988), vol. 171, no. 1-2, pages 45 - 50 | - SUH ET AL., BIOCHEMISTRY, (1998), vol. 37, no. 26, pages 9394 - 8 | - GARRED ET AL., J BIOL CHEM, (1995), vol. 270, no. 18, pages 10817 - 21 | - AUSTIN ET AL., INFECT IMMUN, (1994), vol. 62, no. 5, pages 1768 - 75 | - JACEWICZ ET AL., J EXP MED, (1986), vol. 163, no. 6, pages 1391 - 404 | - LINDBERG ET AL., J BIOLCHEM, (1987), vol. 262, no. 4, pages 1779 - 85 | - WADDELL ET AL., PROC NATL ACAD SCI U S A, (1990), vol. 87, no. 20, pages 7898 - 901 | - DONOHUE-ROLFE ET AL., MOL MICROBIOL, (1989), vol. 3, no. 9, pages 1231 - 6 | - LING ET AL., BIOCHEMISTRY, (1998), vol. 37, no. 7, pages 1777 - 88 | - BAST ET AL., MOL MICROBIOL, (1999), vol. 32, no. 5, pages 953 - 60 | - LING ET AL., STRUCTURE, (2000), vol. 8, no. 3, pages 253 - 64 | - ACHESON ET AL., INFECT IMMUN, (1995), vol. 63, no. 1, pages 301 - 8 | - FRASER ET AL., J BIOL CHEM, (2004), vol. 279, no. 26, pages 27511 - 7 | - PERERA ET AL., J BACTERIOL, (1991), vol. 173, no. 3, pages 1151 - 60 | - O'LOUGHLIN; ROBINS-BROWNE, MICROBES INFECT, (2001), vol. 3, no. 6, pages 493 - 507 | - JACKSON ET AL., MICROB PATHOG, (1987), vol. 2, no. 2, pages 147 - 53 | - SCOTLAND ET AL., EPIDEMIOL INFECT, (1987), vol. 99, no. 3, pages 613 - 24 | - OSTROFF ET AL., J INFECT DIS, (1989), vol. 160, no. 6, pages 994 - 8 | - DONOHUE-ROLFE ET AL., J INFECT DIS, (2000), vol. 181, no. 5, pages 1825 - 9 | - HEAD ET AL., BIOL CHEM, (1991), vol. 266, no. 6, pages 3617 - 21 | - NAKAJIMA ET AL., J BIOL CHEM, (2001), vol. 276, no. 46, pages 42915 - 22 | - TES ET AL., INFECT IMMUN, (1993), vol. 61, no. 8, pages 3392 - 402 | - LOUISE; OBRIG, J INFECT DIS, (1995), vol. 172, no. 5, pages 1397 - 401 | - WEINSTEIN ET AL., INFECT IMMUN, (1989), vol. 57, no. 12, pages 3743 - 50 | - LINGWOOD, TRENDS MICROBIOL, (1996), vol. 4, no. 4, pages 147 - 53 | - MARCATO ET AL., INFECT IMMUN, (2003), vol. 71, no. 10, pages 6075 - 8 | - KITOVA ET AL., J AM SOC MASS SPECTROM, (2005), vol. 16, no. 12, pages 1957 - 68 | - KITOVA ET AL., BIOCHEMISTRY, (2009), vol. 48, no. 23, pages 5365 - 74 | - PINA ET AL., BIOCHEMISTRY, (2003), vol. 42, no. 31, pages 9498 - 506 | - CONRADY ET AL., PLOS ONE, (2010), vol. 5, no. 12, page E15153 | - SCOTLAND ET AL., LANCET, (1985), vol. 2, no. 8460, pages 885 - 6 | - KARMALI ET AL., LANCET, (1986), vol. 1, no. 8473, pages 164 - 5 | - STROCKBINE ET AL., INFECT IMMUN, (1986), vol. 53, no. 1, pages 135 - 40 | - WEN ET AL., VACCINE, (2006), vol. 24, no. 8, pages 1142 - 8 | - BIELASZEWSKA ET AL., INFECT IMMUN, (1997), vol. 65, no. 7, pages 2509 - 16 | - LUDWIG ET AL., CAN J MICROBIOL, (2002), vol. 48, no. 1, pages 99 - 103 | - WADOLKOWSKI ET AL., INFECT IMMUN, (1990), vol. 58, no. 12, pages 3959 - 65 | - GAO ET AL., VACCINE, (2009), vol. 27, no. 14, pages 2070 - 6 | - ZHANG ET AL., VACCINE, (2011), vol. 29, no. 22, pages 3923 - 9 | - TSUJI ET AL., VACCINE, (2008), vol. 26, no. 17, pages 2092 - 9 | - BOERLIN ET AL., J CLINMICROBIOL, (1999), vol. 37, no. 3, pages 497 - 503 | - MACLEOD ET AL., VET PATHOL, (1991), vol. 28, no. 1, pages 66 - 73 | - SCHEIRING ET AL., PEDIATR NEPHROL, (2008), vol. 23, no. 10, pages 1749 - 60 | - SMITH ET AL., VACCINE, (2006), vol. 24, pages 4122 - 4129 | - DONOHUE-ROLFE ET AL., REV INFECT DIS, (1991), vol. 13, no. 4, pages 293 - 297 | - BEUTIN ET AL., J VIRO, (2012), vol. 86, pages 10444 - 10455 | - SCHEUTZ ET AL., EURO SURVEILL, (2011), vol. 16 | - MARCATO ET AL., J INFECT DIS, (2001), vol. 183, pages 435 - 443 | - IMAI ET AL., INFECT IMMUN, (2004), vol. 72, no. 2, pages 889 - 895 | - LAPLAGNE ET AL., PROTEINS, (2004), vol. 57, pages 820 - 828 | - CASSATARO ET AL., VACCINE, (2007), vol. 25, pages 4437 - 4446 | - BELLIDO ET AL., VACCINE, (2009), vol. 27, pages 136 - 145 | - VELIKOVSKY ET AL., INFECT IMMUN, (2003), vol. 71, pages 5750 - 5755 | - ZYLBERMAN ET AL., J BIOICHEM, (2004), vol. 279, pages 8093 - 8101 | - KRATZ ET AL., PROC NATL ACAD SCI U S A, (1999), vol. 96, no. 5, pages 1915 - 1920 | - VOGEL ET AL., PROTEINS, (2005), vol. 58, no. 2, pages 478 - 488 | - FISCHER ET AL., PROC NATL ACAD SCI U S A, (2001), vol. 98, no. 6, pages 3567 - 3570 | - SHIMIZU ET AL., MICROBPATHOG, (2008), vol. 35, no. 1, pages 1 - 9 | - BERGUER ET AL., J IMMUNOL, (2006), vol. 176, pages 2366 - 2372 | - GOLDBAUM ET AL., J. MED. MICROBIOL., (1999), vol. 48, pages 833 - 839 | - RITSERT ET AL., J. MOL. BIOL., (1995), vol. 253, pages 151 - 167 | - BRADEN ET AL., J. MOL. BIOL., (2000), vol. 297, pages 1031 - 1036 | - GOLDBAUM ET AL., J. STRUCT. BIOL., (1998), vol. 123, pages 175 - 178 | - ZYLBERMAN ET AL., J. BIOL. CHEM., (2004), vol. 279, no. 9, pages 8093 - 8101 | - SHAW, D. J.; C. JENKINS; M. C. PEARCE; T. CHEASTY; G. J. GUNN; G. DOUGAN; H. R. SMITH; M. E. WOOLHOUSE; G. FRANKEL, "Shedding patterns of verocytotoxin-producing Escherichia coli strains in a cohort of calves and their dams on a Scottish beef farm", APPL. ENVIRON. MICROBIOL, (2004), vol. 70, pages 7456 - 7465 | - WIDIASIH, D. A.; N. IDO; K. OMOE; S. SUGII; K. SHINAGAWA, "Duration and magnitude of faecal shedding of Shiga toxin-producing Escherichia coli from naturally infected cattle", EPIDEMIOL. INFECT., (2004), vol. 132, pages 67 - 75 | - POTTER, A. A.; S. KLASHINSKY; Y. LI; E. FREY; H. TOWNSEND; D. ROGAN; G. ERICKSON; S. HINKLEY; T. KLOPFENSTEIN; R. A. MOXLEY, "Decreased shedding of Escherichia coli 0157:H7 by cattle following vaccination with type III secreted proteins", VACCINE, (2004), vol. 22, doi:doi:10.1016/j.vaccine.2003.08.007, pages 362 - 369, XP004479356 DOI: http://dx.doi.org/10.1016/j.vaccine.2003.08.007 | - STAMM, I.; M. MOHR; P. S. BRIDGER; E. SCHRO''PFER; M. KO''NIG; W. C. STOFFREGEN; E. A. DEAN-NYSTROM; G. BALJER; C. MENGE, "Epithelial and mesenchymal cells in the bovine colonic mucosa differ in their responsiveness to Escherichia coli Shiga toxin 1", INFECT. IMMUN., (2008), vol. 76, pages 5381 - 5391 | - MENGE, C.; M. BLESSENOHL; T. EISENBERG, . STAMM; G. BALJER, "Bovine ileal intraepithelial lymphocytes represent target cells for Shiga toxin 1 from Escherichia coli.", INFECT. IMMUN, (2004), vol. 72, pages 1896 - 1905 | - MOUSSAY, E.; STAMM, A. TAUBERT; G. BALJER; C. MENGE, "Escherichia coli Shiga toxin 1 enhances IL-4 transcripts in bovine ileal intraepithelial lymphocytes", VET. IMMUNOL. IMMUNOPATHOL., (2006), vol. 113, doi:doi:10.1016/j.vetimm.2006.06.007, pages 367 - 382, XP005622985 DOI: http://dx.doi.org/10.1016/j.vetimm.2006.06.007 | - HOFFMAN, M. A.; C. MENGE; T. A. CASEY; W. LAEGREID; B. T. BOSWORTH; E. A. DEAN-NYSTROM, "Bovine immune response to Shiga-toxigenic Escherichia coli 0157:H7", CLIN. VACCINE IMMUNOL., (2006), vol. 13, doi:doi:10.1128/CVI.00205-06, pages 1322 - 1327, XP008076015 DOI: http://dx.doi.org/10.1128/CVI.00205-06 | - CRAY, W. C., JR.; H. W. MOON, "Experimental infection of calves and adult cattle with Escherichia coli 0157:H7", APPL. ENVIRON. MICROBIOL., (1995), vol. 61, pages 1586 - 1590 | - FROHIICH J1; BALJER G; MENGE C., "Maternally and naturally acquired antibodies to Shiga toxins in a cohort of calves shedding Shiga-toxigenic Escherichia coli.", APPL ENVIRON MICROBIOL, (200906), vol. 75, no. 11, pages 3695 - 704 | - MOHAWK KL; MELTON-CELSA AR; ROBINSON CM; O'BRIEN AD., "Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli 0157:H7.", VACCINE, (2010), vol. 28, pages 4777 - 4785, XP027118994 | - SINCLAIR JF; O'BRIEN AD., "Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli 0157:H7", J BIOL CHEM, (2002), vol. 277, pages 2876 - 2885 | - ROBINSON CM; SINCLAIR JF; SMITH MJ; O'BRIEN AD., "Shiga toxin of enterohemorrhagic Escherichia coli type 0157:H7 promotes intestinal colonization", PROC NATL ACAD SCI U S A, (2006), vol. 103, pages 9667 - 9672 | - CAPOZZO ET AL., INFECT /MMUN, (2003), vol. 71, pages 3971 - 3978 | - CAPOZZO ET AL., INFECT IMMUN, (2003), vol. 71, pages 3971 - 3978 | - AKENAZI ET AL., J. CLINMICROBIOL, (1989), vol. 27, pages 1145 - 1150 |